Jose A. Guerrero
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Human epidermal growth factor receptor 2 (HER2) expression dynamics between diagnosis and recurrence in patients with breast cancer using artificial intelligence and electronic health records: the RosHER study.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: May 09, 2025
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: May 08, 2025
Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial.
Journal: EClinicalMedicine
Published: March 06, 2025
Impact of proximal tibio-fibular joint injury on posterolateral corner knee reconstructions, strategies for achieving knee stability in combined injuries: a systematic review.
Journal: European journal of orthopaedic surgery & traumatology : orthopedie traumatologie
Published: January 13, 2025
Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial.
Journal: Nature medicine
Published: November 05, 2024
HER2DX Genomic Assay in HER2-Positive Early Breast Cancer Treated with Trastuzumab and Pertuzumab: A Correlative Analysis from the PHERGain Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 13, 2024
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab.
Journal: Breast cancer research and treatment
Published: December 26, 2023
Prospective study of HDR brachytherapy (BT), external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT): 10-years experience of an MRI-guided approach.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 24, 2023
Intra-Axial Frontal Cyst with Ependymoma-Like Proliferation: Neuroectodermal or Neurenteric?
Journal: Journal of neuropathology and experimental neurology
Published: October 17, 2020
Last Updated: 09/26/2026